BasharAhmedAqelMD
Gastroenterology • Scottsdale, AZHepatology & Liver Transplantation
Chair, Transplant Center Arizona Mayo Clinic Arizona Professor of Medicine
Dr. Aqel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E. Shea Blvd
Scottsdale, AZ 85259
Summary
- Dr. Bashar Aqel is a gastroenterologist/ Hepatologist in Phoenix, AZ and is affiliated with Mayo Clinic Hospital- Phoenix. He is currently the Chair and Director of the Transplant Center at Mayo Clinic Arizona. He specializes in hepatology & liver transplantation. His research interest include liver transplant outcomes, use of DCD and HCV viremic grafts, and cholangiocarcinoma.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Gastroenterology, 2001 - 2004- Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Transplant Hepatology, 2000 - 2001
University of Missouri-ColumbiaResidency, Internal Medicine, 2000- University of Missouri-ColumbiaInternship, Internal Medicine, 1997 - 1998
University of Jordan Faculty of MedicineClass of 1995
Certifications & Licensure
AZ State Medical License 2007 - 2026
CA State Medical License 2024 - 2026
HI State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
CO State Medical License 2023 - 2025
MN State Medical License 2004 - 2025
FL State Medical License 2000 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Mayo Clinic Quality Fellow: Bronze Level Certification Mayo Clinic Quality Academy, 2011
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis Start of enrollment: 2010 Dec 01
- A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients Start of enrollment: 2020 Sep 10
Publications & Presentations
PubMed
- 127 citationsDonor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.Victor I. Machicao, Hugo Bonatti, Murli Krishna, Bashar Aqel, Frank Lukens
Transplantation. 2004-01-15 - 100 citationsPilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.Thomas DeLeon, Marcela Salomao, Bashar Aqel, Mohamad Bassam Sonbol, Raquel T. Yokoda
Journal of Gastrointestinal Oncology. 2018-12-01 - 110 citationsDirect acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinomaJu Dong Yang, Bashar Aqel, Surakit Pungpapong, Gregory J. Gores, Lewis R. Roberts
Journal of Hepatology. 2016-10-01
Press Mentions
For the First-Ever Arizona Triple Transplant Recipient, the Operation Is Just the BeginningApril 11th, 2023- First Triple-Organ Transplant in Arizona History Gives a New Chance at LifeApril 5th, 2023
- Combination Glecaprevir, Pibrentasvir with Ezetimibe Prevents HCV in TransplantationJune 24th, 2022
- Join now to see all
Committees
- Member, Hepatobiliary Cancer Task Force, Gastroenterology Steering Committee, Mayo Clinic in Arizona 2012 - Present
- Member, Personnel Committee, Diversity Subcommittee, Mayo Clinic in Arizona 2011 - Present
Professional Memberships
- Fellow
- American Association for the Study of Liver DiseasesMember
- Member
- American Society of TransplantationMember
- International Liver Transplantation SocietyMember
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
